Analysis of the involvement of RNA-binding proteins in TAU-dependent neurodegeneration
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
mice, as well as in samples from patients with Alzheimer's disease (AD). This change in expression is evident at both mRNA and protein levels and, in some cases, is accompanied by alterations in their subcellular localization. Our results suggest that RBP dysregulation is a common mechanism in various tauopathies and may be related to impaired TAU functionality. Furthermore, the upregulation of RBPs may represent a compensatory mechanism in response to deficits in synaptic translation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
MAPT mutations, tauopathy, and mechanisms of neurodegeneration
Strang, K. H., Golde, T. E., & Giasson, B. I. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0197-x · Cited by 424
Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity
Vanderweyde, T., Apicco, D. J., Youmans-Kidder, K., Ash, P. E. A., Cook, C., Lummertz da Rocha, E., Jansen-West, K., Frame, A. A., Citro, A., Leszyk, J. D., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.045 · Cited by 342
Cuadrado, A., Martín-Moldes, Z., Ye, J., & Lastres-Becker, I. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540633 · Cited by 320
Self-citationReducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo
Apicco, D. J., Ash, P. E. A., Maziuk, B., LeBlang, C., Medalla, M., Al Abdullatif, A., Ferragud, A., Botelho, E., Ballance, H. I., Dhawan, U., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-017-0022-z · Cited by 281
Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?
Marcelo, A., Koppenol, R., de Almeida, L. P., Matos, C. A., & Nóbrega, C. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03873-8 · Cited by 246
Cellular and pathological functions of tau
Parra Bravo, C., Naguib, S. A., & Gan, L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00753-9 · Cited by 238
Tapia-Rojas, C., Cabezas-Opazo, F., Deaton, C. A., Vergara, E. H., Johnson, G. V. W., & Quintanilla, R. A. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.005 · Cited by 191
Cuadrado, A., Kügler, S., & Lastres-Becker, I. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.010 · Cited by 179
Self-citationFrontotemporal lobar degeneration
Grossman, M., Seeley, W. W., Boxer, A. L., Hillis, A. E., Knopman, D. S., Ljubenov, P. A., Miller, B., Piguet, O., Rademakers, R., Whitwell, J. L., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00447-0 · Cited by 178
Isolation and characterization of Staufen-containing ribonucleoprotein particles from rat brain
Mallardo, M., Deitinghoff, A., Müller, J., Goetze, B., Macchi, P., Peters, C., & Kiebler, M. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0334355100 · Cited by 163
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis
Lastres-Becker, I., Innamorato, N. G., Jaworski, T., Rábano, A., Kügler, S., Van Leuven, F., & Cuadrado, A. (2014) · Brain · doi:10.1093/brain/awt323 · Cited by 160
Self-citationDysregulation of RNA Binding Protein Aggregation in Neurodegenerative Disorders
Maziuk, B., Ballance, H. I., & Wolozin, B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00089 · Cited by 145
The Hippocampus in Neurodegenerative Disease
Moodley, K. K., & Chan, D. (2014) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000356430 · Cited by 142
Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice
Lastres-Becker, I., Brodesser, S., Lütjohann, D., Azizov, M., Buchmann, J., Hintermann, E., Sandhoff, K., Schürmann, A., Nowock, J., & Auburger, G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn035 · Cited by 136
Self-citationRNA-binding proteins balance brain function in health and disease
Schieweck, R., Ninkovic, J., & Kiebler, M. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00047.2019 · Cited by 122
Esteras, N., Rohrer, J. D., Hardy, J., Wray, S., & Abramov, A. Y. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.008 · Cited by 120
Lastres‐Becker, I., Nonis, D., Eich, F., Klinkenberg, M., Gorospe, M., Kötter, P., Klein, F. A. C., Kedersha, N., & Auburger, G. W. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.05.017 · Cited by 115
Self-citationTau interactome and RNA binding proteins in neurodegenerative diseases
Kavanagh, T., Halder, A., & Drummond, E. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00572-6 · Cited by 112
The multifunctional Staufen proteins: conserved roles from neurogenesis to synaptic plasticity
Heraud-Farlow, J. E., & Kiebler, M. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.05.009 · Cited by 112
Friend or foe: The role of stress granule in neurodegenerative disease
Cui, Q., Liu, Z., & Bai, G. (2024) · Neuron · doi:10.1016/j.neuron.2024.04.025 · Cited by 91
Fittschen, M., Lastres‐Becker, I., Halbach, M. V., Damrath, E., Gispert, S., Azizov, M., Walter, M. J., Müller, S., & Auburger, G. W. J. (2015) · Neurogenetics · doi:10.1007/s10048-015-0441-5 · Cited by 83
Self-citationLebeau, G., Maher-Laporte, M., Topolnik, L., Laurent, C. E., Sossin, W., DesGroseillers, L., & Lacaille, J.-C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01844-07 · Cited by 77
Castro-Sánchez, S., García-Yagüe, Á. J., Kügler, S., & Lastres-Becker, I. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101118 · Cited by 76
Self-citationKobayashi, S., Tanaka, T., Soeda, Y., Almeida, O. F. X., & Takashima, A. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.012 · Cited by 74
Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress
Goodman, L. D., Ralhan, I., Li, X., Lu, S., Moulton, M. J., Park, Y.-J., Zhao, P., Kanca, O., Ghaderpour Taleghani, Z. S., Jacquemyn, J., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01740-1 · Cited by 64
Tau induces inflammasome activation and microgliosis through acetylating NLRP3
Zhang, L., Gai, Y., Liu, Y., Meng, D., Zeng, Y., Luo, Y., Zhang, H., Wang, Z., Yang, M., Li, Y., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1623 · Cited by 54
Stress granules: emerging players in neurodegenerative diseases
Yuan, L., Mao, L.-H., Huang, Y.-Y., Outeiro, T. F., Li, W., Vieira, T. C. R. G., & Li, J. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00482-9 · Cited by 52
Tau protein profiling in tauopathies: a human brain study
Lantero‐Rodriguez, J., Camporesi, E., Montoliu‐Gaya, L., Gobom, J., Piotrowska, D., Olsson, M., Matečko‐Burmann, I., Becker, B., Brinkmalm, A., Burmann, B. M., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00741-9 · Cited by 47
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
Galán-Ganga, M., Rodríguez‐Cueto, C., Merchán‐Rubira, J., Hernández, F., Ávila, J., Posada-Ayala, M., Lanciego, J. L., Luengo, E., López, M. G., Rábano, A., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01196-5 · Cited by 47
Self-citationRankin, K. P., Mayo, M. C., Seeley, W. W., Lee, S., Rabinovici, G., Gorno-Tempini, M. L., Boxer, A. L., Weiner, M. W., Trojanowski, J. Q., DeArmond, S. J., et al. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9615-2 · Cited by 44
Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy
LeBlang, C. J., Medalla, M., Nicoletti, N. W., Hays, E. C., Zhao, J., Shattuck, J. E., Cruz, A. L., Wolozin, B. L., & Luebke, J. I. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00285 · Cited by 43
de Sá, R. V., Sudrià-Lopez, E., Luna, M. C., Harschnitz, O., van den Heuvel, D. M. A., Kling, S., Vonk, D., Westeneng, H., Karst, H., Bloemenkamp, L. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51676-0 · Cited by 39
Devi, G. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00015-6 · Cited by 33
Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?
Brackhan, M., Arribas-Blázquez, M., & Lastres‐Becker, I. (2023) · Antioxidants · doi:10.3390/antiox12081564 · Cited by 33
Self-citationDenéchaud, M., Geurs, S., Comptdaer, T., Bégard, S., García-Núñez, A., Pechereau, L.-A., Bouillet, T., Vermeiren, Y., Deyn, P. P. D., Perbet, R., et al. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102386 · Cited by 31
New alternative splicing variants of the ATXN2 transcript
Lastres‐Becker, I., Nonis, D., Nowock, J., & Auburger, G. W. J. (2019) · Neurological Research and Practice · doi:10.1186/s42466-019-0025-1 · Cited by 23
Self-citationTau: More than a microtubule‐binding protein in neurons
Alonso, A. D. C., Idrissi, A. E., Candia, R. F., Morozova, V., & Kleiman, F. E. (2023) · Cytoskeleton · doi:10.1002/cm.21795 · Cited by 23
Emerging roles for innate and adaptive immunity in tauopathies
Johnson, A. M., & Lukens, J. R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116232 · Cited by 20
Tau, RNA, and RNA-Binding Proteins: Complex Interactions in Health and Neurodegenerative Diseases
Lester, E., & Parker, R. (2023) · The Neuroscientist · doi:10.1177/10738584231154551 · Cited by 19
Castro‐Sánchez, S., Zaldívar-Díez, J., Luengo, E., López, M. G., Gil, C., Martínez, A., & Lastres‐Becker, I. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.006 · Cited by 19
Self-citationBorrego‐Hernández, D., Vazquez-Costa, J. F., Domínguez-Rubio, R., Expósito-Blázquez, L., Aller, E., Padró‐Miquel, A., García‐Casanova, P. H., Colomina, M. J., Arriscado, C. M., Osta, R., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12020356 · Cited by 15
Frost, B. E., Rowe, J. B., Akinyemi, R., Abisambra, J. F., Ashton, N. J., Brendel, M., Buée, L., Butler, D., Carrillo, M. C., Chung, P. S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70078 · Cited by 12
Tubulin‐Binding Region Modulates Cholesterol‐Triggered Aggregation of Tau Proteins
Ali, A., Matveyenka, M., Pickett, D. N., Rodriguez, A., & Kurouski, D. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16294 · Cited by 12
Shapley, S. M., Shantaraman, A., Gadhavi, J. D., Kearney, M. A., Dammer, E. B., Duong, D. M., Bowen, C. A., Watson, C. M., Bagchi, P., Guo, Q., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101458 · Cited by 10
Bhopatkar, A. A., Bhatt, N. N., Haque, M. A., Xavier, R., Fung, L., Jerez, C., & Kayed, R. (2024) · Protein Science · doi:10.1002/pro.5099 · Cited by 9
Silva-Llanes, I., Smith, L. A., Abdelkader-Guillén, A., Jiménez-Villegas, J., Sarrió, D., Gema, M.-B., & Lastres‐Becker, I. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-025-01210-1 · Cited by 9
Self-citationTargeting pyroptosis in tauopathies: A redox-driven axis of neuroinflammation and neurodegeneration
López, E. A., Silva-Llanes, I., Diez-Tejedor, E., & Lastres‐Becker, I. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.04.029 · Cited by 4
Self-citationAuburger, G. W. J., Key, J., Gispert, S., Lastres‐Becker, I., Almaguer-Mederos, L.-E., Bassa, C., Auburger, A., Auburger, G. W. J., Arsović, A., Deller, T., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031499 · Cited by 3
Self-citationKuc, C., Brott, J., Thorpe, H. H. A., Smart, A. N., & Vessey, J. P. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147700 · Cited by 2
Research works printed but not linked: 1
- Kovacs, 2017, Tauopathies, Handb. Clin. Neurol., 145, 355
Cited by
mTOR disrupts cerebrovascular RNA regulatory networks in Alzheimer’s diseasePreprint
Makhlouf, H., Banh, A. Q., Pomilio, C. J., Ferrán, B., Hussong, S. A., Saravia, F., Richardson, A. G., & Galván, V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.15.750223
Targeting STAU1 ameliorates disease phenotypes in TDP-43 ALS micePreprint
Spielmann, M., Paul, S., Dansithong, W., Figueroa, K. P., Li, J., Hivare, P., Anderson, C. J., Gandelman, M., & Pulst, S. M. (2026) · Research Square · doi:10.21203/rs.3.rs-11750300/v1
Metadata
- Authors
- Silva-Llanes, I., Baceiredo-Macho, P., & Lastres-Becker, I.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2026-08
- Volume
- 226
- Pages
- 107454
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W7161806769
- Cited by
- 2
- References
- 51
- Citations by year
- 2026: 2
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- Locations
- Neurobiology of Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (publishedVersion, other-oa)
- Funders
- La Caixa Foundation (LCF/BQ/EU24/12060061)
- European Regional Development Fund (PID2022-137065OB-I00)
- Center for Networked Biomedical Research on Neurodegenerative Diseases (CB06/05/0089)
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (PT17/0015/0014, 095024)
- Agencia Estatal de Investigación
- España Ministerio de Ciencia Innovación y Universidades (PID2022-137065OB-I00)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- RNA-binding proteins, tauopathy, Alzheimer's disease, subcellular localization, compensatory mechanisms, mRNA expression
- MeSH terms
- Stress Granules, Alzheimer Disease, Animals, Hippocampus, Humans, Mice, Transgenic, RNA, Messenger, RNA-Binding Proteins, tau Proteins, Tauopathies, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.